Paper Review Records
全部论文审稿周期
18 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
129
天
26
天
65
天
Evaluating early systemic therapies in the neoadjuvant setting for the treatment of urological cancers
作者
Panagiotis Velissarios Stamatakos; Charalampos Fragkoulis; Nikolaos Kontolatis; Konstantinos Gklinos; Christoforos Kourouniotis; Athanasios Dellis展开收起
作者单位
1. General Hospital of Athens “Korgialeneio Benakeio Hellenic Red Cross”; 2. General Hospital of Athens “G. Gennimatas”; 3. National and Kapodistrian University of Athens, Hospital of Athens “Aretaieion”展开收起
140
天
Safety, pharmacokinetics, pharmacodynamics and target-mediated drug disposition modeling of TST002, a sclerostin antibody, in men and postmenopausal women with low bone mineral density
作者
Sufeng Zhou; Xiufen Zhu; Yuchen Sheng; Lu Wang; Feng Shao; Hua Lin展开收起
作者单位
1. The First Affiliated Hospital with Nanjing Medical University; 2. Nanjing Medical University; 3. The Affiliated Hospital of Nanjing University Medical School展开收起
208
天
111
天
Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders
作者
Jonanne Talebloo; Esha Chawla; Donya Shahamati; Swas Shiv; Kishore M. Gadde展开收起
作者单位
1. University of California Irvine School of Medicine; 2. Vanderbilt University School of Medicine; 3. University of California Irvine; 4. Boston University展开收起
FAQ
EXPERT OPINION ON INVESTIGATIONAL DRUGS审稿要多久?
截至2026-11-19,CrushSCI 收录了 EXPERT OPINION ON INVESTIGATIONAL DRUGS 的 18 篇完整审稿记录。最快一篇从收稿到录用用了 26 天(Dual antigen targeting in extramedullary multiple myeloma,2026-09-10 收稿,2026-10-06 录用),最慢一篇用了 334 天;平均 129 天,中位数 130 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
